Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 17Terminated 3Unknown 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 15Gastrointestinal 7Genitourinary 6Endocrine 6Tumor-Agnostic 4Head & Neck 3Sarcoma 2Other solid neoplasm 2Other hematologic neoplasm 2NET 2Thoracic 1Other neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 102Cyclophosphamide 74fludarabine 45Idarubicin 39Decitabine 36Etoposide 35Azacitidine 34Methotrexate 31Daunorubicin 30Vincristine 28Dexamethasone 27venetoclax 25Busulfan 24Imatinib Mesylate 23Radiotherapy 20Mercaptopurine 20Granulocyte Colony-Stimulating Factor 20Dasatinib 19Peripheral Blood Stem Cell Transplantation 18Mitoxantrone 17Doxorubicin 17Immunotherapy, Adoptive 16Rituximab 15Asparaginase 15Tretinoin 14Cladribine 14fludarabine phosphate 13Prednisone 13Prednisolone 13Melphalan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Everolimus × Other hematologic neoplasm × Clear all
NCT00544999 2013-09-17

Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1 Unknown
21 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00636922 2013-02-15

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Bayside Health

Phase 1 Unknown
40 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡